Medicare Law May Offer Opening To Improve Telemedicine Payments – Report
This article was originally published in The Gray Sheet
Executive Summary
CMS' Council for Technology & Innovation could serve as a vehicle to boost the tepid reimbursement environment for device-related health information technology (HIT), according to a report
You may also be interested in...
Richner’s Rule: Consider Reimbursement Early In Technology Development
Possible reimbursement obstacles must be addressed during the initial phases of a technology's conception, Boston Scientific's Randel Richner told attendees at the DeviceCon 2004 summit
Healthcare IT Gets Presidential Treatment; Will Device Firms Benefit?
Innovative reimbursement options for healthcare information technology are necessary to advance the market, according to Daniel Mendelson, managing director of The Health Strategies Consultancy
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.